ESC Premium Access

Mortality of surgical redo aortic valve replacement versus transcatheter aortic valve-in-valve implantation in patients with degenerated aortic bioprosthesis: a meta-analysis.

Congress Session

About the speaker

Doctor Ana Pardo Sanz

Ramon and Cajal University Hospital, Madrid (Spain)
0 follower

5 more presentations in this session

Incidence, risk factors and impact of readmission for heart failure after successful transcatheter aortic valve replacement

Speaker: Doctor P. Guedeney (Paris, FR)


Timing and associated predictors of onset of new conduction disturbances requiring permanent pacemaker implantation after transcatheter aortic valve implantation

Speaker: Miss N. Kooistra (Utrecht, NL)


Validation of the cardiac damage classification and additional effects of albumin levels in a large cohort of patients undergoing transcatheter aortic valve replacement

Speaker: Doctor A. Berkovitch (Ramat Gan, IL)


High H2FPEF score is an independent predictor of adverse outcome in patients with severe aortic stenosis and preserved ejection fraction undergoing TAVR

Speaker: Doctor S. Ludwig (Hamburg, DE)


Stroke after transcatheter aortic valve implantation: an unpredictable risk?

Speaker: Mr G. Bosbach (Duesseldorf, DE)


Access the full session

TAVR outcomes: the future is here

Speakers: Doctor A. Pardo Sanz, Doctor P. Guedeney, Miss N. Kooistra, Doctor A. Berkovitch, Doctor S. Ludwig...

About the event



31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk